Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Cochrane Database of Systematic Reviews|November 1, 2001
Budesonide at different doses for chronic asthmaN Adams, J Bestall, P W Jones
The Cochrane Database of Systematic Reviews|May 2, 2001
Beclomethasone at different doses for chronic asthma (review)N Adams, J Bestall, P Jones
The Cochrane Database of Systematic Reviews|January 27, 2006
Holding chambers versus nebulisers for inhaled steroids in chronic asthmaC J Cates, J Bestall, N Adams
The Cochrane Database of Systematic Reviews|November 1, 2001
Inhaled fluticasone propionate for chronic asthmaN Adams, J Bestall, P W Jones
The Cochrane Database of Systematic Reviews|June 19, 2001
Holding chambers versus nebulisers for inhaled steroids in chronic asthmaC J Cates, N Adams, J Bestall
The Cochrane Database of Systematic Reviews|November 1, 2001
Budesonide for chronic asthma in children and adultsN Adams, J Bestall, P W Jones
Radiography (London, England : 1995)|January 25, 2025
Non-medicinal oral contrast in upper abdominal MRI for MR-guided radiotherapy: A scoping reviewM R Beasley, A M Henry, J Bestall, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
Clinical service organisation for heart failureS Taylor, J Bestall, S Cotter, et al.
Pilot and Feasibility Studies|December 15, 2016
The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Pilot and Feasibility Studies|December 16, 2016
Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Pageof 1